#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia positive acute lymphocytic leukaemia Autoinflammation with infantile enterocolitis Osteosarcoma Andersen-Tawil syndrome Neurotrophic keratopathy Cardiac arrest Endometrial cancer Subdural haematoma Antithrombin III deficiency Cystic fibrosis gastrointestinal disease Penile cancer Congenital pseudarthrosis Short-bowel syndrome Malignant fibrous histiocytoma Pemphigoid More trials…

    Learn about Rare Diseases

    Myxofibrosarcoma – Life with Disease Nephrotic syndrome – Treatment Systemic mastocytosis – Diagnostics Glycogen storage disease type II – Trials in Disease Proteus syndrome Hereditary hypophosphataemic rickets Synovial sarcoma – Life with Disease Friedreich’s ataxia – Trials in Disease Waldenstrom’s macroglobulinaemia – Diagnostics Lysosomal storage disorder – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nortriptyline TRIGLYCERIDES MEDIUM CHAIN Fluticasone Propionate Filgotinib Eftrenonacog Alfa Certolizumab Pegol Ketamine Hydrochloride Pramlintide Acetate HYALURONIDASE Iti-1284 Sufentanil Poloxamer 407 Adrc LUNRESERTIB Lisocabtagene Maraleucel Amantadine Hydrochloride Amb-05X GSKVX000000034798 Dorzolamide Masofaniten More therapies…

    Learn about Your Condition

    Microscopic polyangiitis Follicular lymphoma Stress Rhabdoid tumour of the kidney Acute myeloid leukaemia Spermatocele Rectal cancer stage II Malignant melanoma stage III Colon cancer stage IV Neuroblastoma recurrent Palmoplantar pustulosis Cortical dysplasia Sexual dysfunction Hidradenitis Cutaneous sarcoidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Obesity

  • Study on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Obesity
    Investigated Drugs:
    • Ly3437943 Sodium
    Hungary Poland Slovakia Spain

  • Study on the Effects of Semaglutide on Insulin Resistance and Lipid Metabolism in Women with Obesity and Non-Alcoholic Fatty Liver Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic dysfunction-associated liver disease
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study on Metformin Hydrochloride and Lifestyle Changes for Children and Adolescents with Obesity

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Metformin Hydrochloride
    Sweden

  • Study on the Effects of AZD5004 for Adults with Obesity or Overweight and a Related Medical Condition

    Not recruiting

    2 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Azd5004
    Germany

  • Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

    Not recruiting

    3 1
    Bulgaria Czechia Germany Hungary Poland Romania +2

  • A Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Germany Hungary Ireland Poland
Previous Page
1 … 15 16 17 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!